Download PDF
Thromb Haemost 1999; 82(04): 1361-1362
DOI: 10.1055/s-0037-1614393
Letters to the Editor
Schattauer GmbH

Low-molecular Weight Heparin for Treatment of Pulmonary Embolism in a Pregnant Woman

Steven A. Laifer
1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA
,
Robert J. Stiller
1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA
,
Gina Dunston-Boone
1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA
,
John C. G. Whetham
1   From the Section of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Bridgeport Hospital, Bridgeport, CT, USA
› Author Affiliations
Further Information

Publication History

Received 22 April 1999

Accepted after resubmission 15 June 1999

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Casele H, Laifer S, Woelkers D, Venkataramanan R. Changes in the pharmacokinetics of the low molecular weight heparin enoxaparin during pregnancy. Am J Obstet Gynecol (in press).
    PubMed
  • 2 Andersen DR, Ginsberg JS, Burrows R, Brill-Edwards P. Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery. Thrombosis Haemostasis 1991; 65: 248-50.
    PubMedSearch in Google Scholar
  • 3 Horlocker TT, Wedel DJ. Neuraxial block and low-molecular weight heparin: Balancing perioperative analgesia and thromboprophylaxis. Reg Anes Pain Med 1998; 23 (S) 164-177.
    PubMedSearch in Google Scholar